SE433851B - Forfarande for framstellning av cefalosporinderivat - Google Patents

Forfarande for framstellning av cefalosporinderivat

Info

Publication number
SE433851B
SE433851B SE7705934A SE7705934A SE433851B SE 433851 B SE433851 B SE 433851B SE 7705934 A SE7705934 A SE 7705934A SE 7705934 A SE7705934 A SE 7705934A SE 433851 B SE433851 B SE 433851B
Authority
SE
Sweden
Prior art keywords
procedure
production
cephalosporine derivatives
cephalosporine
derivatives
Prior art date
Application number
SE7705934A
Other languages
English (en)
Swedish (sv)
Other versions
SE7705934L (sv
Inventor
G Palamidessi
F Zarini
G Schioppacassi
F Arcamone
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of SE7705934L publication Critical patent/SE7705934L/xx
Publication of SE433851B publication Critical patent/SE433851B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7705934A 1976-05-21 1977-05-18 Forfarande for framstellning av cefalosporinderivat SE433851B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21032/76A GB1579532A (en) 1976-05-21 1976-05-21 Cephalosporins

Publications (2)

Publication Number Publication Date
SE7705934L SE7705934L (sv) 1977-11-22
SE433851B true SE433851B (sv) 1984-06-18

Family

ID=10156029

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7705934A SE433851B (sv) 1976-05-21 1977-05-18 Forfarande for framstellning av cefalosporinderivat

Country Status (22)

Country Link
US (1) US4148996A (de)
JP (1) JPS52142093A (de)
AT (1) AT355719B (de)
AU (1) AU509448B2 (de)
BE (1) BE854845A (de)
CA (1) CA1102790A (de)
CH (1) CH639095A5 (de)
CS (1) CS199676B2 (de)
DE (1) DE2722666C2 (de)
DK (1) DK216877A (de)
FR (1) FR2424922A1 (de)
GB (1) GB1579532A (de)
GR (1) GR73013B (de)
HU (1) HU174072B (de)
IL (1) IL52123A (de)
NL (1) NL7705262A (de)
NO (1) NO771744L (de)
NZ (1) NZ184110A (de)
SE (1) SE433851B (de)
SU (1) SU799669A3 (de)
YU (1) YU123077A (de)
ZA (1) ZA772859B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017004077A1 (en) * 2015-06-29 2017-01-05 Duke University Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38099A (en) * 1970-12-17 1976-01-30 Smith Kline French Lab 3-heterocyclyl thiomethylcephalosporins
US4007173A (en) * 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
DE2359544A1 (de) * 1973-11-29 1975-10-30 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US3960849A (en) * 1974-03-13 1976-06-01 E. R. Squibb & Sons, Inc. Amino-1,2,4-oxadiazolyl-3-acetyl cephalosporins
DE2512284A1 (de) * 1974-03-28 1975-10-09 Fujisawa Pharmaceutical Co Cephalosporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
CS199676B2 (en) 1980-07-31
NO771744L (no) 1977-11-22
DE2722666C2 (de) 1982-04-15
DK216877A (da) 1977-11-22
GR73013B (de) 1984-01-25
IL52123A (en) 1980-11-30
NZ184110A (en) 1979-08-31
AU2507177A (en) 1978-11-16
ZA772859B (en) 1978-04-26
IL52123A0 (en) 1977-07-31
AT355719B (de) 1980-03-25
JPS52142093A (en) 1977-11-26
FR2424922A1 (fr) 1979-11-30
DE2722666A1 (de) 1977-12-01
CA1102790A (en) 1981-06-09
SU799669A3 (ru) 1981-01-23
SE7705934L (sv) 1977-11-22
NL7705262A (nl) 1977-11-23
HU174072B (hu) 1979-10-28
FR2424922B1 (de) 1983-07-08
US4148996A (en) 1979-04-10
ATA348977A (de) 1979-08-15
CH639095A5 (de) 1983-10-31
AU509448B2 (en) 1980-05-15
BE854845A (fr) 1977-11-21
YU123077A (en) 1982-10-31
GB1579532A (en) 1980-11-19

Similar Documents

Publication Publication Date Title
NO148984C (no) Fremgangsmaate for fremstilling av ammoniakk
PL195154A1 (pl) Sposob wytwarzania eterow zwiazkow hydroksybenzodwuheterocyklicznych
SE7711753L (sv) Forfarande for framstellning av natriumperkarbonat
SE7703815L (sv) Forfarande for framstellning av dispergerbara dispersionspulver
SE7702490L (sv) Forfarande for framstellning av tobaksprodukter
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE7700337L (sv) Forfarande for framstellning av beleggningar
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
FI773738A (fi) Foerfarande foer framstaellning av n-(bentstiazol-2-yl)-oxamidsyra-derivat
SE433081B (sv) Forfarande for framstellning av cefalosporinforeningar
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE7703628L (sv) Forfarande for framstellning av resoler
NO143384C (no) Fremgangsmaate for fremstilling av stivelseloesning
PL197704A1 (pl) Sposob wytwarzania nowych pochodnych indazoliloksy 4-propanoloaminy
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE7711964L (sv) Forfarande for framstellning av gamma-pyroner
SE7811142L (sv) Forfarande for framstellning av prostacylinderivat
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE433354B (sv) Forfarande for framstellning av cefalosporinderivat
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE7709429L (sv) Forfarande for framstellning av elektroder
SE7704003L (sv) Forfarande for framstellning av livsmedel
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE433851B (sv) Forfarande for framstellning av cefalosporinderivat